Nurix Therapeutics, Inc. | ||||
NGM : NRIX || Location: United States | ||||
$14.7+0.16 (+1.1%) |
1.27 M | 14.18 - 15.33 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 6.408 M |
Feb. 29, 2024 | 6.846 M |
Feb. 15, 2024 | 7.270 M |
Jan. 31, 2024 | 7.285 M |
Jan. 12, 2024 | 7.014 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.58 | -0.77 | -32.44% |
09/30/2023 | -0.77 | -0.68 | 11.79% |
06/30/2023 | -0.57 | -0.45 | 21.22% |
03/31/2023 | -0.89 | -0.75 | 15.29% |
02/28/2023 | -0.87 | -0.75 | 13.80% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 48.894M | Shares Float | 37.425M |
Short Float | 6.408M | Market Cap | 710.92M |
Institution ownership | 98.59% | Insider ownership | 2.664% |
Earnings Date | 04/10/2024 AMC | Cash Per Share | ? |
Trailing EPS | -2.65 | Forward EPS | -3.11 |